Mallinckrodt to enter Irish examinership after US plan approved

American-Irish pharmaceuticals manufacturer Mallinckrodt will file examinership proceedings in Dublin in the coming days, after the Delaware bankruptcy court approved its Chapter 11 plan to slash about US$1.3 billion in debt.

Get unlimited access to all Global Restructuring Review content